On September 22, a bipartisan group of 86 members of Congress sent a letter urging leaders of the House of Representatives to invest in medical research and protect funding for the National Institutes of Health (NIH).
The President’s budget, released earlier this year, proposed a big cut for NIH, primarily by imposing limits on funding for facilities and administration (F&A) costs. These F&A costs (also referred to as indirect costs) help cover critical components of medical research, including “hazardous waste disposal, proper and secure storage of dangerous pathogens, maintenance of high-tech labs and essential personnel.”
The letter, which ASCO endorsed, explains that, “Simply put, scientists cannot conduct research for the federal government without incurring these costs… Accelerating the development of new cures, therapies and vaccines demands that we continue to support vital research costs like these.”
Earlier this month, Congress passed a Continuing Resolution that keeps funding for NIH and the National Cancer Institute (NCI) flat through December 8, 2017. ASCO urges Congress to support a $2 billion increase for NIH, and thanks the bipartisan group of lawmakers for their support for the biomedical research infrastructure.
Read the letter.
Continue reading ASCO in Action for the latest news on cancer policy.